ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb Ischemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01311011
Recruitment Status : Unknown
Verified December 2011 by King Faisal Specialist Hospital & Research Center.
Recruitment status was:  Recruiting
First Posted : March 9, 2011
Last Update Posted : December 13, 2011
Sponsor:
Information provided by (Responsible Party):
King Faisal Specialist Hospital & Research Center

Brief Summary:
Phase II Prospective Study of the Clinical Efficacy of Autologous SCT in patients with Critical Limb Ischemia

Condition or disease Intervention/treatment
Critical Limb Ischemia Procedure: SCT

Detailed Description:
Phase II Prospective Study of the Clinical Efficacy of Autologous SCT in patients with Critical Limb Ischemia

Study Type : Observational
Estimated Enrollment : 26 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Phase II Prospective Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb Ischemia
Study Start Date : November 2008

Intervention Details:
    Procedure: SCT
    SCT



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   14 Years to 85 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with Critical Limb Ischemia
Criteria

Inclusion Criteria:

  • Patients with Critical Limb Ischemia

Exclusion Criteria:

  • Patients with other than Critical Limb Ischemia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01311011


Contacts
Contact: H Al-Zahrani, M.D. +966-1-4423949

Locations
Saudi Arabia
Kfsh & Rc Recruiting
Riyadh, Saudi Arabia
Sponsors and Collaborators
King Faisal Specialist Hospital & Research Center
Investigators
Principal Investigator: H Al-Zahrani, M.D. KFSH & RC

Responsible Party: King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier: NCT01311011     History of Changes
Other Study ID Numbers: RAC# 2081-026
First Posted: March 9, 2011    Key Record Dates
Last Update Posted: December 13, 2011
Last Verified: December 2011

Keywords provided by King Faisal Specialist Hospital & Research Center:
Critical Limb Ischemia

Additional relevant MeSH terms:
Ischemia
Pathologic Processes